title,link,date
Announcement under Regulation 30 (LODR)-Press Release / Media Release 18h - FDA approves Sun Pharma's next-gen LED BLU-U device for actinic keratosis treatment.,https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=314a871d-122a-4298-b8f6-5082ec9f2313.pdf,18h - FDA approves Sun Pharma's next-gen LED BLU-U device for actinic keratosis treatment.
"Announcement under Regulation 30 (LODR)-Press Release / Media Release 12 May - Sun Pharma to announce Q4 FY25 results and hold earnings call on May 22, 2025.",https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=69e938a5-c495-451b-81c6-716c7261c43f.pdf,"12 May - Sun Pharma to announce Q4 FY25 results and hold earnings call on May 22, 2025."
"Board Meeting Intimation for Approval Of Audited Financial Results For The Year Ended 31 March 2025, And Final Dividend, If Any 12 May - Board meeting on 22 May to approve FY25 results and consider final dividend; trading window closed till 24 May.",https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f6c3754-709f-4f11-8c36-401378a6a35e.pdf,12 May - Board meeting on 22 May to approve FY25 results and consider final dividend; trading window closed till 24 May.
"Announcement under Regulation 30 (LODR)-Press Release / Media Release 8 May - Sun Pharma launches multi-language corporate brand campaign 'touching 1,000 lives every minute' in India.",https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0d5ec57-5d00-4f80-ace2-97ad1a178496.pdf,"8 May - Sun Pharma launches multi-language corporate brand campaign 'touching 1,000 lives every minute' in India."
"Announcement under Regulation 30 (LODR)-Change in Management 6 May - Sun Pharma appoints Jayashree Satagopan as CFO effective 1 July 2025, succeeding retiring CFO Muralidharan.",https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=51ed859f-936e-4d48-a748-304022ce934f.pdf,"6 May - Sun Pharma appoints Jayashree Satagopan as CFO effective 1 July 2025, succeeding retiring CFO Muralidharan."
